Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors

被引:6
作者
Meqbil, Yazan J. [1 ]
van Rijn, Richard M. [2 ,3 ]
机构
[1] Purdue Univ, Dept Med Chem & Mol Pharmacol, Computat Interdisciplinary Grad Program, W Lafayette, IN 47907 USA
[2] Purdue Univ, Purdue Inst Drug Discovery, Purdue Inst Neurosci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[3] Septerna Inc, San Francisco, CA 94080 USA
关键词
mutagenesis; artificial intelligence; computer-aided drug design; molecular dynamic simulation; biased signaling; G protein-coupled receptor; POSITIVE ALLOSTERIC MODULATORS; MOLECULAR PHARMACOLOGY; RESPIRATORY DEPRESSION; GENETIC-VARIATION; SINGLE RESIDUE; HIGH-AFFINITY; AGONIST; BINDING; LIGAND; ACTIVATION;
D O I
10.3390/ph15070873
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The delta opioid receptor is a Gi-protein-coupled receptor (GPCR) with a broad expression pattern both in the central nervous system and the body. The receptor has been investigated as a potential target for a multitude of significant diseases including migraine, alcohol use disorder, ischemia, and neurodegenerative diseases. Despite multiple attempts, delta opioid receptor-selective molecules have not been translated into the clinic. Yet, the therapeutic promise of the delta opioid receptor remains and thus there is a need to identify novel delta opioid receptor ligands to be optimized and selected for clinical trials. Here, we highlight recent developments involving the delta opioid receptor, the closely related mu and kappa opioid receptors, and in the broader area of the GPCR drug discovery research. We focus on the validity and utility of the available delta opioid receptor structures. We also discuss the increased ability to perform ultra-large-scale docking studies on GPCRs, the rise in high-resolution cryo-EM structures, and the increased prevalence of machine learning and artificial intelligence in drug discovery. Overall, we pose that there are multiple opportunities to enable in silico drug discovery at the delta opioid receptor to identify novel delta opioid modulators potentially with unique pharmacological properties, such as biased signaling.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia
    Dripps, Isaac J.
    Bertels, Zachariah
    Moye, Laura S.
    Tipton, Alycia F.
    Siegersma, Kendra
    Baca, Serapio M.
    Kieffer, Brigitte L.
    Pradhan, Amynah A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [22] Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
    Karaki, Fumika
    Takamori, Taro
    Kawakami, Koumei
    Sakurai, Sae
    Hidaka, Kyoko
    Ishii, Kei
    Oki, Tomoya
    Sato, Noriko
    Atsumi, Nao
    Ashizawa, Karin
    Taguchi, Ai
    Ura, Asuka
    Naruse, Toko
    Hirayama, Shigeto
    Nonaka, Miki
    Miyano, Kanako
    Uezono, Yasuhito
    Fujii, Hideaki
    MOLECULES, 2023, 28 (19):
  • [23] Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors
    Johnson, Stephen M.
    Turner, Sara M. F.
    NEURONS AND NETWORKS IN THE SPINAL CORD, 2010, 1198 : 260 - 270
  • [24] GCDB: a glaucomatous chemogenomics database for in silico drug discovery
    Wei, Yu
    Li, Jinlong
    Li, Baiqing
    Ma, Chunfeng
    Xu, Xuanming
    Wang, Xu
    Liu, Aqin
    Du, Tengfei
    Wang, Zhonghua
    Hong, Zhangyong
    Lin, Jianping
    DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION, 2018,
  • [25] Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes
    Brissett, D. I.
    Whistler, J. L.
    van Rijn, R. M.
    EUROPEAN JOURNAL OF PAIN, 2012, 16 (03) : 327 - 337
  • [26] The opioid receptors as targets for drug abuse medication
    Noble, Florence
    Lenoir, Magalie
    Marie, Nicolas
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (16) : 3964 - 3979
  • [27] In Silico Drug Discovery Approaches on Grid Computing Infrastructures
    Wolf, Antje
    Shahid, Mohammad
    Kasam, Vinod
    Ziegler, Wolfgang
    Hofmann-Apitius, Martin
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (01): : 37 - 46
  • [28] AI Trustworthy Challenges in Drug Discovery
    Ahadian, Pegah
    Guan, Qiang
    TRUSTWORTHY ARTIFICIAL INTELLIGENCE FOR HEALTHCARE, TAI4H 2024, 2024, 14812 : 1 - 12
  • [29] Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities
    Haroun, Ryma
    Naasri, Sahar
    Oweida, Ayman J.
    VACCINES, 2023, 11 (04)
  • [30] Diversity in synthetic perchlorate anion receptors: Challenges and opportunities
    Guchhait, Tapas
    Roy, Satabdi
    Das, Monalisha
    Jena, Swoyan Prava
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1292